The global life science software market is expected to reach a valuation of US$ 13,736 million in 2023. The key growth factors driving the market are increasing research and development, expanding biotech number and size, and increasing cost efficiencies. The overall sales of life science software are projected to grow at a robust CAGR of 7.5% between 2023 and 2033, totaling around US$ 31,151.8 million by the end of 2033.
Life science is a branch of science concerned with the research of living organisms. Biology, anatomy, health sciences, medical sciences, and pharmaceutics are all fields of study in life science. In today's evolving healthcare ecosystem, life science software aids in developing comprehensive, integrated solutions to the life science industry, such as product quality, regulatory compliance, speed, cost-effectiveness, and many others.
| Data Points | Key Statistics |
|---|---|
| Life Science Software Market Size (2023) | US$ 13,736 million |
| Life Science Software Market Revenue Forecast (2033) | US$ 31,151.8 million |
| Life Science Software Market Growth Rate (2023 to 2033) | 7.5% CAGR |
| North America Market Share | 40.5% |
Life science software includes various tools for standardizing workflow and managing documentation to serve the biopharmaceutical, medical technology, generics, and clinical care industries. These programs allow corporations to record, store, and preserve information through images and text. Various types of life science software are available, along with drug identification and affirmation, laboratory management, clinical trial management, and medical device innovation.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Continuous technological innovations, the accessibility of big data in the life science industry, the increasing adoption of analytics techniques in clinics and hospitals as well as for sales and promotion in the pharmaceutical companies, and the burgeoning need for enhanced patient care shipment are some of the major factors driving the expansion of the life science software market.
Furthermore, factors such as an increase in the frequency of chronic diseases, massive pressure to reduce healthcare spending, and a bigger emphasis on value-based medicine all contribute to the significant growth of this market.
However, aspects such as the elevated cost of implementing life science software, complex programming, additional infrastructure, and data management costs limit the expansion of the life science software market.
Principal Consultant
Due to the elevated adoption of cutting-edge technologies and a substantial majority of investments, North America dominates the life science software market. Because of the escalating digitization of healthcare-related work processes and the presence of major healthcare firms implementing this software in these regions, North America is the leading market in the life science software market. It is expected to grow rapidly over the next decade.
The United States is the key industry in North America for life science software. The market in this region will develop faster than South America's. The demand for security, easy access to data, and productive patient information management will aid the growth of the life science software industry. North America is accounting for a market share of 40.5% of the global life science software market.
The European life science software market is expected to grow at a 9% CAGR. During the forecast period, the European life science software sector is predicted to account for the largest share of the global market. Geographically, the European life science software market accounted for a sizable share of the overall in 2020 and is anticipated to grow at a healthy rate during the forecast period.
During the forecast period, the German life science software market is expected to be a lucrative business regional market in Europe. The German market benefits from social advancements such as censuses and technological advancements such as digitization. The growing use of IoT and cloud computing is expected to boost the life science software market. Europe is accounting for a market share of 24% of the global life science software market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The biopharmaceutical segment's life science software market share will develop significantly during the forecast period. Life science software can benefit biopharmaceutical companies by providing a global healthcare standard. It bolsters the functionalities of logistic partners and collaborates with trading partners such as contract packagers. During the forecast period, these characteristics will drive segment growth.
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interests of potential buyers and create a larger customer base. For instance,
Some of the leading life science software providers include Oracle Corporation, Deloitte, SAP SE, Accelrys Software, Inc., Cegedim SA, Medidata Solution, Inc., Revitas, Inc., Veeva Systems, Inc., Model N, Inc., SAS Institute, Inc., PTC Therapeutics, Inc., TIBCO Software, Inc., and Perceptive Informatics, Inc.
These key life science software providers are adopting various strategies, such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc., to increase their sales and gain a competitive edge in the global life science software market. For instance,
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.5% from 2023 to 2032 |
| Expected Market Value (2023) | US$ 13,736 million |
| Anticipated Forecast Value (2033) | US$ 31,151.8 million |
| Base Year for Estimation | 2023 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The market in 2023 is valued at US$ 13,736 million.
The market is estimated to reach US$ 31,151.8 million by 2033.
The market is likely to expand at a 7.5% CAGR through 2033.
The market rose at a 6% CAGR from 2018 to 2022.
North America accounts for 40.5% of revenue in 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 5.3.1. for Research and Development 5.3.2. for Clinical Trials 5.3.3. for Drug Safety 5.3.4. for Sales and Marketing Support 5.3.5. for Regulatory Compliance 5.3.6. for Supply Chain Analytics 5.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 6.3.1. for Healthcare Institutes 6.3.2. for Biopharmaceutical Industry 6.3.3. for Medical Devices Industry 6.3.4. for Medical Research Centers 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Deployment, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Deployment, 2023 to 2033 7.3.1. On-Premise Deployment 7.3.2. Hosted Deployment 7.4. Y-o-Y Growth Trend Analysis By Deployment, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Deployment, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Application 9.2.3. By End User 9.2.4. By Deployment 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Application 9.3.3. By End User 9.3.4. By Deployment 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Application 10.2.3. By End User 10.2.4. By Deployment 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Application 10.3.3. By End User 10.3.4. By Deployment 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Application 11.2.3. By End User 11.2.4. By Deployment 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Application 11.3.3. By End User 11.3.4. By Deployment 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Application 12.2.3. By End User 12.2.4. By Deployment 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Application 12.3.3. By End User 12.3.4. By Deployment 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Application 13.2.3. By End User 13.2.4. By Deployment 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Application 13.3.3. By End User 13.3.4. By Deployment 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Application 14.2.3. By End User 14.2.4. By Deployment 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Application 14.3.3. By End User 14.3.4. By Deployment 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Application 15.2.3. By End User 15.2.4. By Deployment 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Application 15.3.3. By End User 15.3.4. By Deployment 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Application 16.1.2.2. By End User 16.1.2.3. By Deployment 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Application 16.2.2.2. By End User 16.2.2.3. By Deployment 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Application 16.3.2.2. By End User 16.3.2.3. By Deployment 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Application 16.4.2.2. By End User 16.4.2.3. By Deployment 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Application 16.5.2.2. By End User 16.5.2.3. By Deployment 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Application 16.6.2.2. By End User 16.6.2.3. By Deployment 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Application 16.7.2.2. By End User 16.7.2.3. By Deployment 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Application 16.8.2.2. By End User 16.8.2.3. By Deployment 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Application 16.9.2.2. By End User 16.9.2.3. By Deployment 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Application 16.10.2.2. By End User 16.10.2.3. By Deployment 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Application 16.11.2.2. By End User 16.11.2.3. By Deployment 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Application 16.12.2.2. By End User 16.12.2.3. By Deployment 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Application 16.13.2.2. By End User 16.13.2.3. By Deployment 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Application 16.14.2.2. By End User 16.14.2.3. By Deployment 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Application 16.15.2.2. By End User 16.15.2.3. By Deployment 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Application 16.16.2.2. By End User 16.16.2.3. By Deployment 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Application 16.17.2.2. By End User 16.17.2.3. By Deployment 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Application 16.18.2.2. By End User 16.18.2.3. By Deployment 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Application 16.19.2.2. By End User 16.19.2.3. By Deployment 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Application 16.20.2.2. By End User 16.20.2.3. By Deployment 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Application 16.21.2.2. By End User 16.21.2.3. By Deployment 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Application 16.22.2.2. By End User 16.22.2.3. By Deployment 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Application 16.23.2.2. By End User 16.23.2.3. By Deployment 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Application 17.3.3. By End User 17.3.4. By Deployment 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Oracle Corporation 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Deloitte 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. SAP SE 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Accelrys Software Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Cegedim SA 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Medidata Solution Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Revitas Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Veeva Systems Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Model N Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. SAS Institute Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. PTC Therapeutics Inc. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. TIBCO Software Inc. 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Perceptive Informatics Inc. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Healthcare
February 2022
REP-GB-472
June 2022
250 pages
Explore Technology Insights
View Reports
Life Science Software Market
